BA vs PPCB · P/E 89, rev $89.46B vs P/E 0.0, $3.9M cap
The Boeing Company (BA) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
PPCB does not have a complete income-statement cache yet.
BA currently screens at market cap $177.86B and trailing P/E 89.2. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the BA and PPCB stock pages for the full models.
Not investment advice.